CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← Mechanisms of action

Secretory phospholipase A2

PROTEIN FAMILYHomo sapiens
Children:PLA2G2CPLA2G2APLA2G2EPLA2G10PLA2G2FPLA2G1BPLA2G2DPLA2G5PLA2G3PLA2G12A

Linked proteins

  • Group 10 secretory phospholipase A2 (PLA2G10) ↗
  • Phospholipase A2 (PLA2G1B) ↗
  • Phospholipase A2, membrane associated (PLA2G2A) ↗
  • Calcium-dependent phospholipase A2 (PLA2G5) ↗
  • Putative inactive group IIC secretory phospholipase A2 (PLA2G2C) ↗
  • Group XIIA secretory phospholipase A2 (PLA2G12A) ↗
  • Group IIF secretory phospholipase A2 (PLA2G2F) ↗
  • Group 3 secretory phospholipase A2 (PLA2G3) ↗
  • Group IIE secretory phospholipase A2 (PLA2G2E) ↗
  • Group IID secretory phospholipase A2 (PLA2G2D) ↗
  • Group XIIB secretory phospholipase A2-like protein (PLA2G12B) ↗

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.